New Clinical Trial Aims to Reprogram Cells to Attack a Specific Relapsed Blood Cancer

An upcoming clinical trial at The James aims to reprogram a patient’s immune cells to attack a specific relapsed blood cancer, called multiple myeloma. Read More

An upcoming clinical trial at The James aims to reprogram a patient’s immune cells to attack a specific relapsed blood cancer, called multiple myeloma. The idea is to “super-charge” the patient’s immune system so that it responds to the cancer by attacking it – all while offering the patient a drug-free treatment alternative. Read More

Using Genomics to Improve Lung Cancer Treatment

Genomics – the study of the genetic makeup of an organism – helps researchers and oncologists pinpoint why there is no routine lung cancer. Read More

Genomics – the study of the genetic makeup of an organism – helps researchers and oncologists pinpoint why there is no routine lung cancer. Every lung cancer has a unique set of genetic abnormalities, and studying an individual’s genomics allows experts to gain insights into that person's unique cancer. Read More

5 Sneak Peeks at the New Home of The James [Part 3]

Our vision to create a cancer-free world, one person, one discovery at a time, will become a reality only through the integration of research into clinical cancer care. Read More

Our vision to create a cancer-free world, one person, one discovery at a time, will become a reality only through the integration of research into clinical cancer care. These sneak peeks inside the new home of the The James Cancer Hospital and Solove Research Institute will demonstrate how discoveries in the lab translate to improved patient care for even our sickest patients. Read More

Researchers Develop New Treatment Method for Pancreatic Cancer

An estimated 46,420 people in the United States will be diagnosed with pancreatic cancer in 2014. Read More

An estimated 46,420 people in the United States will be diagnosed with pancreatic cancer in 2014. Fortunately, research experts at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James) are constantly innovating to find new ways to treat the disease. Read More

Addressing False Positivity in Lung Cancer Screening

One out of four individuals at high risk of lung cancer who receive a low-dose CT scan as part of the lung cancer screening process will have a spot on their lung. Read More

One out of four individuals at high risk of lung cancer who receive a low-dose CT scan as part of the lung cancer screening process will have a spot on their lung. Of those patients, 96.3 percent will be found to not have cancer. In many cases, the only way to confirm whether a spot is cancerous is an invasive procedure that can be expensive and stressful while possibly causing medical complications. Read More

5 Sneak Peeks at the New Home of The James [Part 2]

This week, we take an even deeper look inside our 21st-century cancer hospital at some of the unique and innovative features Ohio State is bringing to cancer care and treatment. Read More

Last week, we took you on a sneak peek of the new home of The James Cancer Hospital and Solove Research Institute to show the 15th floor, cancer infusion bays, building mechanicals, technology and operating rooms. This week, we take an even deeper look inside our 21st-century cancer hospital at some of the unique and innovative features Ohio State is bringing to cancer care and treatment. Read More

Team Buckeye Rider Finds New Meaning for Pelotonia Ride

This year, Anna Maria Bittoni will ride in Pelotonia for the second time, completing the 100-mile journey from Columbus to Gambier to support cancer research at the OSUCCC – James. Read More

This year, Anna Maria Bittoni will ride in Pelotonia for the second time, completing the 100-mile journey from Columbus to Gambier to support cancer research at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James). As a member of Team Buckeye, Ohio State’s superpeloton (riding group), Bittoni was given an opportunity to participate in the “I Ride For You” program, which matches Team Buckeye student riders with patients of the OSUCCC – James. Read More

Pelotonia-Supported Clinical Trial Returns Patient to Active Lifestyle

Wally Yocum, has a biology degree from Fairleigh-Dickinson University in New Jersey that he pursued partly because he thought, “Maybe I could help find a cure for something.” Read More

Wally Yocum, a technical manager at the Marietta branch of Koroseal Interior Products, LLC, has a biology degree from Fairleigh-Dickinson University in New Jersey that he pursued partly because he thought, “Maybe I could help find a cure for something." Years later, he did just that by participating in clinical trials for patients with chronic lymphocytic leukemia (CLL) at The Ohio State University Comprehensive Cancer Center – James Cancer Hospital and Solove Research Institute (OSUCCC – James). Read More